Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
International Journal of Molecular Sciences|March 28, 2026
Targeting Neuropeptide Y/DPP4 Signalling Suppresses Ewing Sarcoma Survival and Improves Monocyte ViabilityRobin M H Rumney, Dariusz C GóreckiMethods in Molecular Biology (Clifton, N.J.)|October 25, 2019
Knockout and Knock-in Mouse Models to Study Purinergic SignalingRobin M H Rumney, Dariusz C GóreckiJournal of Cellular Biochemistry|June 26, 2024
Investigating the Involvement of C-X-C Motif Chemokine 5 and P2X7 Purinoceptor in Ectopic Calcification in Mouse Models of Duchenne Muscular DystrophyRobin M H Rumney, Joanna Pomeroy, Dariusz C GóreckiFrontiers in Pharmacology|August 1, 2022
P2X7 Purinoceptor Affects Ectopic Calcification of Dystrophic MusclesRobin M H Rumney, Justyna Róg, Natalia Chira, et al.Current Opinion in Pharmacology|March 23, 2019
P2X7 purinoceptor as a therapeutic target in muscular dystrophiesDariusz C GóreckiInternational Journal of Molecular Sciences|June 10, 2023
The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular DystrophiesKrzysztof Zabłocki, Dariusz C GóreckiCurrent Opinion in Pharmacology|February 26, 2023
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathiesDariusz C Gόrecki, Robin M H RumneyHuman Molecular Genetics|June 8, 2024
Ablation of the dystrophin Dp71f alternative C-terminal variant increases sarcoma tumour cell aggressivenessNancy Alnassar, Jacek Hajto, Robin M H Rumney, et al.Expert Opinion on Emerging Drugs|August 31, 2006
Emerging vectors and targeting methods for nonviral gene therapyMatthieu D Lavigne, Dariusz C GóreckiPageof 8